These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8566349)

  • 41. Proceedings: Monoamine oxidase active site; the binding to and titration of monoamine oxidase with (14C)-selective inhibitors.
    Youdim MB
    Br J Pharmacol; 1976 Mar; 56(3):375P. PubMed ID: 1260203
    [No Abstract]   [Full Text] [Related]  

  • 42. Inhibition of monoamine oxidase by 3,4-dihydro-2(1H)-quinolinone derivatives.
    Meiring L; Petzer JP; Petzer A
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5498-502. PubMed ID: 24012182
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders.
    Binda C; Newton-Vinson P; Hubálek F; Edmondson DE; Mattevi A
    Nat Struct Biol; 2002 Jan; 9(1):22-6. PubMed ID: 11753429
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Understanding the Molecular Determinant of Reversible Human Monoamine Oxidase B Inhibitors Containing 2H-Chromen-2-One Core: Structure-Based and Ligand-Based Derived Three-Dimensional Quantitative Structure-Activity Relationships Predictive Models.
    Mladenović M; Patsilinakos A; Pirolli A; Sabatino M; Ragno R
    J Chem Inf Model; 2017 Apr; 57(4):787-814. PubMed ID: 28291352
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monoamine oxidase inhibitor properties of some benzazoles: structure-activity relationships.
    Grandi T; Sparatore F; Gnerre C; Crivori P; Carrupt PA; Testa B
    AAPS PharmSci; 1999; 1(4):E16. PubMed ID: 11741212
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and evaluation of β-carboline derivatives as potential monoamine oxidase inhibitors.
    Reniers J; Robert S; Frederick R; Masereel B; Vincent S; Wouters J
    Bioorg Med Chem; 2011 Jan; 19(1):134-44. PubMed ID: 21183355
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Benzopyrone Biochanin-A as a reversible, competitive, and selective monoamine oxidase B inhibitor.
    Zarmouh NO; Eyunni SK; Soliman KF
    BMC Complement Altern Med; 2017 Jan; 17(1):34. PubMed ID: 28069007
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel hydrazine molecules as tools to understand the flexibility of vascular adhesion protein-1 ligand-binding site: toward more selective inhibitors.
    Nurminen EM; Pihlavisto M; Lázár L; Pentikäinen U; Fülöp F; Pentikäinen OT
    J Med Chem; 2011 Apr; 54(7):2143-54. PubMed ID: 21405023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis, monoamine oxidase inhibition activity and molecular docking studies of novel 4-hydroxy-N'-[benzylidene or 1-phenylethylidene]-2-H/methyl/benzyl-1,2-benzothiazine-3-carbohydrazide 1,1-dioxides.
    Saddique FA; Zaib S; Jalil S; Aslam S; Ahmad M; Sultan S; Naz H; Iqbal M; Iqbal J
    Eur J Med Chem; 2018 Jan; 143():1373-1386. PubMed ID: 29126721
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alteration in spectral properties on ligand binding reveals flexibility in monoamine oxidase.
    Ramsay RR; Jones TZ; Hynson RM
    Med Sci Monit; 2005 Sep; 11(9):SR15-20. PubMed ID: 16127378
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural and mechanistic studies of arylalkylhydrazine inhibition of human monoamine oxidases A and B.
    Binda C; Wang J; Li M; Hubalek F; Mattevi A; Edmondson DE
    Biochemistry; 2008 May; 47(20):5616-25. PubMed ID: 18426226
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures.
    Binda C; Li M; Hubalek F; Restelli N; Edmondson DE; Mattevi A
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9750-5. PubMed ID: 12913124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modification of a spectrophotometric method for assessment of monoamine oxidase activity with 2,4-dinitrophenylhydrazine as a derivatizing reagent.
    Vinel PK; Grobovoy SI; Sinitskii AI; Kolesnikov OL
    Anal Biochem; 2021 Sep; 629():114294. PubMed ID: 34197779
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exploring 4-substituted-2-thiazolylhydrazones from 2-, 3-, and 4-acetylpyridine as selective and reversible hMAO-B inhibitors.
    Chimenti P; Petzer A; Carradori S; D'Ascenzio M; Silvestri R; Alcaro S; Ortuso F; Petzer JP; Secci D
    Eur J Med Chem; 2013 Aug; 66():221-7. PubMed ID: 23807114
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Crystal structures, binding interactions, and ADME evaluation of brain penetrant N-substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A/B inhibitors.
    Tzvetkov NT; Stammler HG; Neumann B; Hristova S; Antonov L; Gastreich M
    Eur J Med Chem; 2017 Feb; 127():470-492. PubMed ID: 28107736
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potent and selective MAO-B inhibitory activity: amino- versus nitro-3-arylcoumarin derivatives.
    Matos MJ; Rodríguez-Enríquez F; Vilar S; Santana L; Uriarte E; Hripcsak G; Estrada M; Rodríguez-Franco MI; Viña D
    Bioorg Med Chem Lett; 2015 Feb; 25(3):642-8. PubMed ID: 25532905
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of the discriminable stimulus produced by 2-BFI: effects of imidazoline I(2)-site ligands, MAOIs, beta-carbolines, agmatine and ibogaine.
    MacInnes N; Handley SL
    Br J Pharmacol; 2002 Mar; 135(5):1227-34. PubMed ID: 11877331
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dual inhibitors of cholinesterases and monoamine oxidases for Alzheimer's disease.
    Knez D; Sova M; Košak U; Gobec S
    Future Med Chem; 2017 May; 9(8):811-832. PubMed ID: 28504893
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives.
    Delogu G; Picciau C; Ferino G; Quezada E; Podda G; Uriarte E; Viña D
    Eur J Med Chem; 2011 Apr; 46(4):1147-52. PubMed ID: 21316817
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monoamine oxidase inhibitory activity in tobacco particulate matter: Are harman and norharman the only physiologically relevant inhibitors?
    Truman P; Grounds P; Brennan KA
    Neurotoxicology; 2017 Mar; 59():22-26. PubMed ID: 28057462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.